Jon Stewart and Sen. Kirsten Gillibrand stand with New York City first responders during a rally on Capitol Hill

Jon Stewart and Sen. Kirsten Gillibrand stand with New York City first responders during a rally on Capitol Hill Lauren Victoria Burke/AP

9/11 First-Responders – With Jon Stewart – Hit the Hill

The former “Daily Show” host is continuing a crusade to renew expiring legislation that provides health care to September 11 first-responders.

Comedi­an Jon Stew­art had a mes­sage for the hun­dreds of fire­fight­ers and po­lice who des­cen­ded on Cap­it­ol Hill Wed­nes­day to pres­sure Con­gress to re­new health care be­ne­fits for 9/11 first-re­spon­ders, which be­gin to ex­pire next month: He’s sorry.

“I want to apo­lo­gize to all the men and wo­men, first-re­spon­ders, that you had to come down here today,” Stew­art said at a rally in front of the Cap­it­ol Wed­nes­day morn­ing. “I’m em­bar­rassed. I’m em­bar­rassed for our coun­try, I’m em­bar­rassed for New York, I’m em­bar­rassed that you, after serving so self­lessly, with such hero­ism, have to come down here and con­vince people to do what’s right for the ill­nesses and dif­fi­culties that you suffered be­cause of your hero­ism and be­cause of your self­less­ness. Nobody had to lobby you to rush to­ward those towers that day.”

But Stew­art, formerly of The Daily Show, also offered a warn­ing to first-re­spon­ders: “Today on the Hill, you will be ex­posed to pos­sibly tox­ic levels of bull­shit and ar­rog­ance.”

Stew­art was joined by hun­dreds of first-re­spon­ders as well as Sen. Kirsten Gil­librand and Reps. Car­o­lyn Malo­ney, Jerry Nadler, and Peter King, all mem­bers from New York who have sponsored the James Za­d­roga 9/11 Health and Com­pens­a­tion Reau­thor­iz­a­tion Act. Gil­librand and oth­ers have cred­ited Stew­art’s con­sist­ent rib­bing of mem­bers of Con­gress who op­posed the bill in 2010 with help­ing to get it passed in the first place.

The bill, which provides com­pens­a­tion and health care be­ne­fits to 9/11 first-re­spon­ders, be­gins to ex­pire this month. It in­cludes the World Trade Cen­ter Health Pro­gram, which pays for health care for first-re­spon­ders and will ex­pire on Septem­ber 30, though the fund can be drawn from for an ad­di­tion­al year. It also in­cludes the Septem­ber 11th Vic­tim Com­pens­a­tion Fund, which provides ad­di­tion­al funds to vic­tims and ex­pires in Oc­to­ber 2016.

There may already be some move­ment on the is­sue. Asked Wednesday wheth­er the pro­gram should be ex­ten­ded and wheth­er that could be part of a con­tinu­ing res­ol­u­tion, Sen­ate Ma­jor­ity Lead­er Mitch Mc­Con­nell said: “I’m go­ing to be meet­ing with first re­spon­ders later today my­self, and we do plan to ex­tend the pro­gram and the com­mit­tees of jur­is­dic­tion in the House and the Sen­ate are ac­tu­ally work­ing on the de­tails now.”

The ex­act de­tails of what Mc­Con­nell is pro­pos­ing re­main un­clear, but New York Sen. Chuck Schu­mer re­spon­ded: “That is great news at last.”

The bill al­most died in 2010 and was ini­tially voted down in the House, amid Re­pub­lic­an con­cerns over the cost of the bill and that it was, at the time, per­man­ent. Gil­librand and oth­ers helped to ne­go­ti­ate a deal with Sens. Tom Coburn, now re­tired, and Mi­chael En­zi, to shorten its au­thor­iz­a­tion to six years, a deal that passed the Sen­ate un­an­im­ously.

Sup­port­ers now hope to push Con­gress to make both pro­grams per­man­ent, cit­ing ad­di­tion­al re­search link­ing dis­eases to tox­ins found at the 9/11 site and sim­il­ar funds set up for coal-miners and former nuc­le­ar work­ers. More than 4,100 first-re­spon­ders and sur­viv­ors have con­trac­ted can­cer re­lated to 9/11, ac­cord­ing to the Cen­ters for Dis­ease Con­trol, while more than 33,000 have at least one re­lated ill­ness or in­jury.

So far, the bill has 151 co-spon­sors in the House, in­clud­ing 33 Re­pub­lic­ans, and 37 spon­sors in the Sen­ate, in­clud­ing six Re­pub­lic­an mem­bers.

Asked why the reau­thor­iz­a­tion is needed now, while both pro­grams will con­tin­ue to op­er­ate for the next year, Stew­art said: “My feel­ing is if you have stage 4 can­cer and you get a let­ter of no­ti­fic­a­tions say­ing that the medi­cine you rely on may be end­ing in a year, that to me is an ur­gent-care situ­ation. … These ill­nesses that they have are not on five-year cycles.”

Stew­art noted that of the four first-re­spon­ders he in­ter­viewed on his show in 2010, one of them, John Devlin, has “already passed away” from re­lated ill­nesses.

T.J. Gil­martin, a first-re­spon­der who ran to the towers from a high rise he was build­ing in Man­hat­tan on 9/11, noted that there could be many more cases of ill­ness to come, long after the cur­rent Za­d­roga bill ex­pires. “I have an as­bes­tos su­per­visor’s li­cense. As­bes­tos and meso­the­lioma, there’s a 20-year lag time on that. … What is five years go­ing to do? It’s not ex­actly 20 years. [In] 2020, 2022, you could have a lot of guys dy­ing from lung can­cer,” he said. The Meso­the­lioma Cen­ter says the latency peri­od can typ­ic­ally run any­where from 20 to 50 years.

The hun­dreds of first-re­spon­ders, and their fam­il­ies, who came to the Cap­it­ol Wed­nes­day in­clude Joseph Za­d­roga, whose son James was the first New York Po­lice De­part­ment of­ficer to die of com­plic­a­tions from the tox­ic chem­ic­als at the site of the World Trade Cen­ter towers. They hope to vis­it 535 con­gres­sion­al of­fices, thank­ing those mem­bers who have already signed onto the reau­thor­iz­a­tion bill and try­ing to con­vince mem­bers who haven’t to join the ef­fort.

John Feal, a first-re­spon­der and the founder of the Feal­Good Found­a­tion that ad­voc­ates for fel­low 9/11 re­spon­ders, helped to or­gan­ize the rally and of­fice vis­its on Wed­nes­day. “We’re here to chal­lenge Con­gress to be an Amer­ic­an, to be a hu­man be­ing with com­pas­sion,” Feal said at Wed­nes­day’s rally. “But we’re also not go­ing to take no for an an­swer. …  I’m go­ing to put my foot in their ass. I’m not go­ing to sug­ar­coat this—foot to ass—be­cause this is about hu­man life. We’re talk­ing about men and wo­men dy­ing.”

Feal said that he and oth­er first-re­spon­ders have now made 14 trips to Wash­ing­ton this year to urge mem­bers of Con­gress to per­man­ently reau­thor­ize the Za­d­roga bill and have held 300 meet­ings with mem­bers be­fore Wed­nes­day’s rally. “They will re­mem­ber Septem­ber 16, not be­cause of a de­bate to­night, be­cause a bunch of hard-core ass-kick­ing 9/11 first-re­spon­ders walked the halls of Con­gress to fight for the tens of thou­sands that couldn’t be here,” Feal told sup­port­ers.

NEXT STORY: Meet the New Hillary

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.